Endoscopic Lung Volume Reduction with Valves Improves Cardiovascular Adaptability and 6-MWT Performance in Severely Limited COPD Patients

Lara Farber, Eva Pappe, Thomas Sgarbossa, Konrad Neumann, Martin Witzenrath, Ralf-Harto Hübner, Jacopo Saccomanno · 2026

Read Endoscopic Lung Volume Reduction with Valves Improves Cardiovascular Adaptability and 6-MWT Performance in Severely Limited COPD Patients by Lara Farber, Eva Pappe, Thomas Sgarbossa, Konrad Neumann, Martin Witzenrath, Ralf-Harto Hübner, Jacopo Saccomanno (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13286814.txt.

Description

Lara Farber and colleagues revisit who benefits most from lung valve treatment in severe emphysema in a 2026 retrospective study. One-way valves deflate the worst lung lobe, yet patients who can barely walk were long excluded from trials as too risky. Records of 54 Berlin patients were split at a six-minute walking distance of 140 meters, comparing lung function, quality of life, and walk-test details after treatment.

Both groups gained lung function and quality of life to a similar degree. The frailest walkers, though, added far more distance than the stronger group, a mean gain past one hundred meters against roughly a dozen. Their heart rates also settled further from baseline to follow-up, hinting at a cardiovascular dividend, while oxygen levels changed alike. The authors argue the lowest walkers should not be turned away.

Catalog record

CREATORLara Farber, Eva Pappe, Thomas Sgarbossa, Konrad Neumann, Martin Witzenrath, Ralf-Harto Hübner, Jacopo Saccomanno
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE46177
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13286814

Browse the full library · About the Tower of Babel